SCHEMBL23699792

SCHEMBL23699792

CCC(N)(CN)C(CC)(CC)CC

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL181857 0.81 CYP2D6 (0.30) CYP2D6
Water SCHEMBL6722953 0.80
Hydrochloric Acid SCHEMBL5849096 0.80
Bromide SCHEMBL6742918 0.77
SCHEMBL309317 0.71 TSHR (0.39)
SCHEMBL25264479 0.71 CYP2D6 (0.32) CYP2D6
SCHEMBL181815 0.71
Sulfuric Acid SCHEMBL4752454 0.69 TP53 (0.32)
Perchlorate SCHEMBL31108769 0.69
SCHEMBL2709936 0.69 CYP2D6 (0.37) CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 86 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250372697-A1 METHOD FOR PRODUCING SOLID ELECTROLYTE, AND ELECTROLYTE PRECURSOR IDEMITSU KOSAN CO.,LTD. (JP) 2025-12-04 US claimed
US-12612313-B2 Method for producing lithium halide compound IDEMITSU KOSAN CO., LTD. (JP) 2026-04-28 US disclosed
US-20260008676-A1 METHOD FOR MANUFACTURING SULFIDE SOLID ELECTROLYTE IDEMITSU KOSAN CO.,LTD. (JP) 2026-01-08 US disclosed
US-20250372697-A1 METHOD FOR PRODUCING SOLID ELECTROLYTE, AND ELECTROLYTE PRECURSOR IDEMITSU KOSAN CO.,LTD. (JP) 2025-12-04 US disclosed
EP-4657469-A1 METHOD FOR PRODUCING SULFIDE SOLID ELECTROLYTE Idemitsu Kosan Co.,Ltd. (JP) 2025-12-03 EP disclosed
US-12489139-B2 Method for producing solid electrolyte IDEMITSU KOSAN CO., LTD. (JP) 2025-12-02 US disclosed
EP-4159678-B1 METHOD FOR PRODUCING LITHIUM HALIDE COMPOUND IDEMITSU KOSAN CO (JP) 2025-10-01 EP disclosed
US-12381253-B2 Solid electrolyte containing a thio-lisicon region II crystal structure IDEMITSU KOSAN CO., LTD. (JP) 2025-08-05 US disclosed
US-20250201909-A1 METHOD FOR MANUFACTURING SULFIDE SOLID ELECTROLYTE IDEMITSU KOSAN CO.,LTD. (JP) 2025-06-19 US disclosed
US-20250183359-A1 CRYSTALLINE SULFIDE SOLID ELECTROLYTE AND METHOD FOR PRODUCING SAME IDEMITSU KOSAN CO.,LTD. (JP) 2025-06-05 US disclosed
US-20210376377-A1 METHOD FOR PRODUCING SOLID ELECTROLYTE IDEMITSU KOSAN CO., LTD. (JP) 2021-12-02 US disclosed
WO-2021241405-A1 METHOD FOR PRODUCING LITHIUM HALIDE COMPOUND 出光興産株式会社 2021-12-02 WO disclosed
US-20210351434-A1 METHOD FOR PRODUCING SULFIDE SOLID ELECTROLYTE IDEMITSU KOSAN CO., LTD. (JP) 2021-11-11 US disclosed
US-11139505-B2 Method for producing solid electrolyte, and electrolyte precursor IDEMITSU KOSAN CO., LTD. (JP) 2021-10-05 US disclosed
EP-3886119-A1 SULFIDE SOLID ELECTROLYTE AND TREATMENT METHOD THEREFOR Idemitsu Kosan Co.,Ltd. (JP) 2021-09-29 EP disclosed
EP-3886122-A1 METHOD FOR PRODUCING SOLID ELECTROLYTE, AND ELECTROLYTE PRECURSOR Idemitsu Kosan Co.,Ltd. (JP) 2021-09-29 EP disclosed
US-20210249685-A1 METHOD FOR PRODUCING SOLID ELECTROLYTE, AND ELECTROLYTE PRECURSOR IDEMITSU KOSAN CO.,LTD. (JP) 2021-08-12 US disclosed
US-20210242496-A1 SULFIDE SOLID ELECTROLYTE AND TREATMENT METHOD THEREFOR IDEMITSU KOSAN CO., LTD. (JP) 2021-08-05 US disclosed
CN-112384993-A Sulfide solid electrolyte and method for treating same 出光兴产株式会社 2021-02-19 CN disclosed
CN-112334999-A Method for producing solid electrolyte and electrolyte precursor 出光兴产株式会社 2021-02-05 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260008676-A1 METHOD FOR MANUFACTURING SULFIDE SOLID ELECTROLYTE CACNA1S, CACNA1A, VRK2 CYP2D6 4131/4885
US-12612313-B2 Method for producing lithium halide compound CLCN2, SLC6A12, CLIC1 CYP2D6 3188/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.